(Adnkronos) - “Mi è sempre più chiaro come soltanto un'integrazione della ricerca nel settore sia della salute mentale, sia del benessere psicologico e delle neuroscienze, quindi sulle malattie neurodegenerative, sia la risposta alle nuove sfide che ci stanno venendo. Un cambiamento di prospettiva legata a un'idea di salute completamente diversa da quello che poteva essere un decennio fa”. Così Gemma Calamandrei, direttrice Centro di riferimento per le scienze comportamentali e la salute mentale dell'Iss, intervenendo all’evento istituzionale ‘La salute parte dal cervello. Le Neuroscienze in Italia. Passato, presente e futuro’ promosso a Palazzo dell’informazione a Roma dall’azienda biofarmaceutica danese specializzata nelle neuroscienze Lundbeck Italia, in occasione del 30° anniversario di attività e impegno nel nostro Paese.
Category
🗞
NewsTranscript
00:00What are you working on?
00:04We are working all over the field.
00:06There is a department of Neuroscience,
00:08also in the Department of Health,
00:09of which I have been the director of Interim in the last year,
00:12and it is increasingly clear to me how
00:14only an integration of research
00:16in the sector of both mental health,
00:18psychological well-being and neuroscience,
00:21therefore on neurodegenerative diseases,
00:23is the answer to the new challenges that are coming.
00:25A change of perspective that is linked
00:27to a health idea that is completely different
00:29from what it could have been a decade ago.
00:31Today we know that many neurological diseases
00:35also have an impact on the mental health of people.
00:39So an important aspect is to promote
00:42epidemiological and clinical research,
00:45which allows an integration between the most classic fields
00:48of neuroscience, neurological sciences
00:50and the field of mental health.
00:52This multidisciplinary contribution, in my opinion,
00:55can bring a lot of progress in this sector,
00:57but you have to invest in research.
00:59Research, research, research, I always say that.
01:01I work in a large public biomedical research institute,
01:04which is CENITALIA, the Institute of Superior Health.
01:06And if we reduce the work of the institute
01:09to aspects simply of control,
01:11we lose that richness, that approach,
01:13that meeting of basic research
01:15and epidemiological clinical research,
01:17which is the key to the success
01:19and the transfer of innovative therapies in this sector.